Combining Best-in-Class TCRs, Next Generation Technologies & Optimal Manufacturing to Mediate Optimal Anti-Tumor Response

Time: 3:30 pm
day: Conference Day Two


  • MyT platformTM, a unique T-cell receptor and unbiased epitope discovery engine
  • Next-generation approaches to engage the broader immune system and promote resistance to the tumor microenvironment
  • Process development that selects for memory phenotype